Ignite Creation Date:
2025-12-25 @ 1:24 AM
Ignite Modification Date:
2026-04-10 @ 2:17 AM
Study NCT ID:
NCT00139893
Status:
COMPLETED
Last Update Posted:
2013-03-26
First Post:
2005-08-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Randomized, Open-label, Two-way Crossover Trial to Determine the Pharmacokinetics of Metoclopramide When Administered as the Orally Disintegrating Tablet Compared to Reglan® Tablets in Subjects With Diabetic Gastroparesis
Sponsor:
UCB Pharma
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
SP850
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None